Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Namenda
Namenda
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
Fierce Pharma
Tue, 11/15/22 - 06:37 pm
legal
AbbVie
Namenda
Alzheimer's disease
pay-for-delay
Allergan
Allergan pays $750m to avoid Alzheimer’s drug lawsuit
Pharmaforum
Mon, 10/28/19 - 11:31 pm
Allergan
Namenda
Alzheimer's disease
settlement
Allergan counting on January formulary boost to jump-start Namzaric launch
Fierce Pharma Marketing
Wed, 11/11/15 - 09:54 am
Allergan
formulary
Namzaric
Alzheimer's disease
Aricept
Namenda
Eisai
Supreme Court asked to review Namenda product switching case
Pharmalot
Tue, 11/10/15 - 08:30 am
Supreme Court
Namenda
Namenda XR
Allergan
Alzheimer's disease
hard switch
Advera Health Analytics: Novartis, Allergan Alzheimer's meds linked to abnormal behavior, blood pressure side effects
Fierce Pharma
Sun, 10/11/15 - 01:57 pm
Novartis
Allergan
Alzheimer's disease
Eisai
Exelon Patch
Namenda
Aricept
Allergan braces for $200M sales hit as Namenda generics roll
Fierce Pharma
Wed, 07/15/15 - 06:17 pm
Allergan
Namenda
generics
Mylan
Dr Reddy's
Alzheimer's disease
The legal death of Actavis' Namenda strategy spells doom for the 'hard switch'
Fierce Pharma
Tue, 05/26/15 - 10:53 am
Actavis
Namenda
generics
hard switch
Alzheimer's disease
No Namenda hard switch? No problem, Actavis execs say, with Namzaric on the horizon
Fierce Pharma Marketing
Mon, 05/18/15 - 11:32 am
Actavis
Namenda
hard switch
Namenda XR
Namzaric
Alzheimer's disease
Actavis Wins a ‘Product Hopping’ Case as Namenda Battle Rages On
WSJ Pharmalot
Tue, 04/21/15 - 01:34 pm
Actavis
Namenda
Namenda XR
hard switch
Alzheimer's disease
Actavis: No apologies for seeking Alzheimer's drug profits
Yahoo/AP
Mon, 04/13/15 - 10:06 pm
Actavis
Alzheimer's disease
Namenda
Namenda XR
A Threat to Drugmakers’ Hard Switch
Bloomberg
Thu, 04/9/15 - 03:13 pm
Actavis
Namenda XR
Namenda
hard switch
Namenda antitrust suit heats up in NY court
BioPharma Dive
Fri, 03/20/15 - 11:04 am
Namenda
Actavis
Namenda XR
antitrust
Alzheimer's disease
Why the Actavis Product Switching Case may Transform Pharma
WSJ Pharmalot
Thu, 01/15/15 - 05:47 pm
Actavis
Namenda
Namenda XR
generics
Can Actavis Switch Enough Namenda Patients Before Generics Arrive?
WSJ Pharmalot
Tue, 01/13/15 - 04:39 pm
Actavis
generics
Namenda
Alzheimer's disease
Court to Decide Next Month on Actavis Tactic for its Alzheimer’s Drug
WSJ Pharmalot
Wed, 01/7/15 - 11:46 am
Actavis
Alzheimer's disease
Namenda
Namenda XR
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
Judge blocking switch of patented Alzheimer's drugs until July; manufacturer to appeal
Yahoo/AP
Tue, 12/16/14 - 08:02 am
Alzheimer's disease
Namenda
Actavis
The End of the Hard Switch? What the Judge Says About an Actavis Tactic
WSJ Pharmalot
Mon, 12/15/14 - 12:32 pm
Actavis
Namenda
Alzheimer's disease
Actavis is Ordered to Continue Selling the Namenda Alzheimer’s Pill
WSJ Pharmalot
Thu, 12/11/14 - 08:05 pm
Actavis
Namenda
Alzheimer's disease
What Will the NY AG Anti-Trust Lawsuit Mean for Actavis?
WSJ Pharmalot
Wed, 09/17/14 - 04:37 pm
antitrust
Actavis
Namenda XR
Namenda
Alzheimer's disease
Pages
1
2
next ›
last »